Cargando…
Lipocalin-2 released in response to cerebral ischaemia mediates reperfusion injury in mice
Thrombolysis remains the only effective therapy to reverse acute ischaemic stroke. However, delayed treatment may cause serious complications including hemorrhagic transformation and reperfusion injury. The level of lipocalin-2 (LCN2) is elevated in the plasma of ischaemic stroke patients, but its r...
Autores principales: | Wang, Guona, Weng, Yi-Chinn, Han, Xiqian, Whaley, James D, McCrae, Keith R, Chou, Wen-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511361/ https://www.ncbi.nlm.nih.gov/pubmed/25702801 http://dx.doi.org/10.1111/jcmm.12538 |
Ejemplares similares
-
Neutralization of Lipocalin-2 Diminishes Stroke-Reperfusion Injury
por: Wang, Guona, et al.
Publicado: (2020) -
Lipocalin-2 in Stroke
por: Chou, Wen-Hai, et al.
Publicado: (2015) -
Identification of lipocalin-2 as a PKCδ phosphorylation substrate in neutrophils
por: Weng, Yi-Chinn, et al.
Publicado: (2015) -
Effect of Neurosteroid Modulation on Global Ischaemia-Reperfusion-Induced Cerebral Injury in Mice
por: Grewal, Amarjot Kaur, et al.
Publicado: (2013) -
HDAC9 exacerbates endothelial injury in cerebral ischaemia/reperfusion injury
por: Shi, Weichen, et al.
Publicado: (2016)